These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31063103)

  • 41. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission.
    Li Y; Han Y; Xie J; Gu L; Li W; Wang H; Lv W; Song X; Li Y; Routy JP; Ishida T; Iwamoto A; Li T;
    AIDS; 2014 Feb; 28(4):521-30. PubMed ID: 24472744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant.
    Soulie C; Morand-Joubert L; Cottalorda J; Charpentier C; Bellecave P; Le Guen L; Yerly S; Montes B; Fafi-Kremer S; Dina J; Avettand-Fenoel V; Amiel C; Roussel C; Pallier C; Zafilaza K; Sayon S; Signori-Schmuck A; Mirand A; Trabaud MA; Berger S; Calvez V; Marcelin AG;
    J Clin Virol; 2018; 99-100():57-60. PubMed ID: 29331843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.
    Dimonte S; Svicher V; Salpini R; Ceccherini-Silberstein F; Perno CF; Babakir-Mina M
    Arch Virol; 2011 Nov; 156(11):1943-51. PubMed ID: 21814863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients.
    Mortier V; Dauwe K; Vancoillie L; Staelens D; Van Wanzeele F; Vogelaers D; Vandekerckhove L; Chalmet K; Verhofstede C
    PLoS One; 2013; 8(11):e80259. PubMed ID: 24244665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. X4 Tropic Virus Prediction Is Associated with a Nadir CD4 T-Cell Count below 100 Cells/mm.
    Sechet M; Roussel C; Schmit JL; Saroufim C; Ghomari K; Merrien D; Cordier F; Pik JJ; Landgraf N; Douadi Y; Liné D; Duverlie G; Castelain S
    Intervirology; 2015; 58(3):155-9. PubMed ID: 25997386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials.
    Lewis M; Mori J; Toma J; Mosley M; Huang W; Simpson P; Mansfield R; Craig C; van der Ryst E; Robertson DL; Whitcomb JM; Westby M
    PLoS One; 2018; 13(12):e0204099. PubMed ID: 30586365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.
    Symons J; van Lelyveld SF; Hoepelman AI; van Ham PM; de Jong D; Wensing AM; Nijhuis M
    J Antimicrob Chemother; 2011 Apr; 66(4):890-5. PubMed ID: 21393136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing.
    Raymond S; Saliou A; Nicot F; Delobel P; Dubois M; Carcenac R; Sauné K; Marchou B; Massip P; Izopet J
    J Antimicrob Chemother; 2013 Dec; 68(12):2875-81. PubMed ID: 23869053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Position 22 of the V3 loop is associated with HIV infectivity.
    Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
    Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
    Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concordance of HIV type 1 tropism phenotype to predictions using web-based analysis of V3 sequences: composite algorithms may be needed to properly assess viral tropism.
    Cabral GB; Ferreira JL; Coelho LP; Fonsi M; Estevam DL; Cavalcanti JS; Brígido LF
    AIDS Res Hum Retroviruses; 2012 Jul; 28(7):734-8. PubMed ID: 21919801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.
    Santoro MM; Armenia D; Fabeni L; Santoro M; Gori C; Forbici F; Svicher V; Bertoli A; Dori L; Surdo M; Balestra E; Palamara G; Girardi E; Angarano G; Andreoni M; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
    Clin Microbiol Infect; 2012 Aug; 18(8):E289-98. PubMed ID: 22681969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.
    Hayashida T; Tsuchiya K; Kikuchi Y; Oka S; Gatanaga H
    PLoS One; 2017; 12(5):e0177033. PubMed ID: 28472121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. V3 net charge: additional tool in HIV-1 tropism prediction.
    Montagna C; De Crignis E; Bon I; Re MC; Mezzaroma I; Turriziani O; Graziosi C; Antonelli G
    AIDS Res Hum Retroviruses; 2014 Dec; 30(12):1203-12. PubMed ID: 25322170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotypic tropism prediction from paired cell and plasma using single and replicate sequences.
    Coelho LP; Ferreira JL; Cabral GB; Guimarães PM; Brigido LF
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):711-6. PubMed ID: 24673579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.
    Kitawi RC; Hunja CW; Aman R; Ogutu BR; Muigai AW; Kokwaro GO; Ochieng W
    Virol J; 2017 Feb; 14(1):29. PubMed ID: 28196510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV co-receptor tropism prediction remains stable over time in treatment-naïve patients.
    Philip KE; Macartney MJ; Conibear TC; Smith CJ; Marshall N; Johnson MA; Haque T; Webster DP
    Int J STD AIDS; 2016 Jun; 27(7):576-80. PubMed ID: 25999168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.
    Lewis ME; Simpson P; Mori J; Jubb B; Sullivan J; McFadyen L; van der Ryst E; Craig C; Robertson DL; Westby M
    Antivir Chem Chemother; 2021; 29():20402066211030380. PubMed ID: 34343443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.